Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse MKT  >  Oragenics Inc    OGEN

ORAGENICS INC

(OGEN)
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Oragenics: 2Q Earnings Snapshot

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 07:24pm EDT

TAMPA, Fla. (AP) _ Oragenics Inc. (OGEN) on Wednesday reported a loss of $4.8 million in its second quarter.

The Tampa, Florida-based company said it had a loss of 10 cents per share.

In the final minutes of trading on Wednesday, the company's shares hit 36 cents. A year ago, they were trading at 50 cents.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OGEN at https://www.zacks.com/ap/OGEN

Automated Insights, source Associated Press News

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ORAGENICS INC
08/14ORAGENICS : 2Q Earnings Snapshot
AQ
08/14ORAGENICS : Quarterly report pursuant to Section 13 or 15(d) Related Documents E..
PU
08/14ORAGENICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
06/25ORAGENICS, INC. : to Present Data on Its Peptide Synthesis Platform at the Ameri..
BU
06/24ORAGENICS : Initial registration statement for securities to be offered to emplo..
PU
06/21ORAGENICS : Current report filing Related Documents EX-4.5
PU
06/21ORAGENICS INC : Submission of Matters to a Vote of Security Holders, Financial S..
AQ
06/17ORAGENICS : Recent Peer-Reviewed Publication on Oragenics, Inc.'s Lantibiotic An..
PU
05/20ORAGENICS, INC. : Provides Development Update of AG013 for Oral Mucositis
BU
05/16ORAGENICS : Definitive proxy statements
PU
More news
Chart ORAGENICS INC
Duration : Period :
Oragenics Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Alan F. Joslyn President, Chief Executive Officer & Director
Frederick W. Telling Non-Executive Chairman
Michael O'Keefe Sullivan Chief Financial Officer, Secretary & Treasurer
Robert C. Koski Director
Charles L. Pope Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORAGENICS INC-56.26%17
CSL LIMITED22.81%69 599
BIOGEN INC.-24.36%41 986
ALEXION PHARMACEUTICALS13.86%24 450
GRIFOLS25.41%19 155
SAMSUNG BIOLOGICS CO LTD--.--%15 813